Author: | Kenneth Kee | ISBN: | 9780463268803 |
Publisher: | Kenneth Kee | Publication: | August 6, 2018 |
Imprint: | Smashwords Edition | Language: | English |
Author: | Kenneth Kee |
ISBN: | 9780463268803 |
Publisher: | Kenneth Kee |
Publication: | August 6, 2018 |
Imprint: | Smashwords Edition |
Language: | English |
This book describes Essential Thrombocytosis, Diagnosis and Treatment and Related Diseases
Essential thrombocytosis (ET) is a medical disorder in which the bone marrow produces too many platelets.
Platelets are a part of the blood that helps in blood clotting.
Thrombocytosis is measured as a platelet count above the upper limit of the normal range (450 x 109/L in adults)
It is essential to differentiate between true hematological disease causing primary thrombocytosis and secondary or reactive thrombocytosis produced by an overstated physiological response to a primary disorder.
Primary or essential thrombocytosis is a chronic myeloproliferative disorder (produced by bone marrow).
Causes
Essential thrombocytosis happens from an overproduction of platelets.
Untreated, ET becomes worse over time.
Since these platelets do not work normally, blood clots and bleeding are frequent disorders.
ET is part of a group of disorders known as myeloproliferative disorders.
Others are:
Symptoms
Frequent symptoms of blood clots may be:
Diagnosis
Most of the time, Essential thrombocytosis is found through blood tests done for other health complaints before symptoms occur.
The doctor may detect an enlarged liver or spleen on physical examination.
The patient may also have abnormal blood flow in the toes or feet that produces skin injuries in these areas.
Other tests may be:
Treatment
The treatment requires an evaluation of the patient's risk and where possible taking remedial action.
Patients with essential thrombocythemia are regarded as having high risk of:
TABLE OF CONTENT
Introduction
Chapter 1 Essential Thrombocytosis
Chapter 2 Causes
Chapter 3 Symptoms
Chapter 4 Diagnosis
Chapter 5 Treatment
Chapter 6 Prognosis
Chapter 7 Low Platelets
Chapter 8 High Platelets
Epilogue
This book describes Essential Thrombocytosis, Diagnosis and Treatment and Related Diseases
Essential thrombocytosis (ET) is a medical disorder in which the bone marrow produces too many platelets.
Platelets are a part of the blood that helps in blood clotting.
Thrombocytosis is measured as a platelet count above the upper limit of the normal range (450 x 109/L in adults)
It is essential to differentiate between true hematological disease causing primary thrombocytosis and secondary or reactive thrombocytosis produced by an overstated physiological response to a primary disorder.
Primary or essential thrombocytosis is a chronic myeloproliferative disorder (produced by bone marrow).
Causes
Essential thrombocytosis happens from an overproduction of platelets.
Untreated, ET becomes worse over time.
Since these platelets do not work normally, blood clots and bleeding are frequent disorders.
ET is part of a group of disorders known as myeloproliferative disorders.
Others are:
Symptoms
Frequent symptoms of blood clots may be:
Diagnosis
Most of the time, Essential thrombocytosis is found through blood tests done for other health complaints before symptoms occur.
The doctor may detect an enlarged liver or spleen on physical examination.
The patient may also have abnormal blood flow in the toes or feet that produces skin injuries in these areas.
Other tests may be:
Treatment
The treatment requires an evaluation of the patient's risk and where possible taking remedial action.
Patients with essential thrombocythemia are regarded as having high risk of:
TABLE OF CONTENT
Introduction
Chapter 1 Essential Thrombocytosis
Chapter 2 Causes
Chapter 3 Symptoms
Chapter 4 Diagnosis
Chapter 5 Treatment
Chapter 6 Prognosis
Chapter 7 Low Platelets
Chapter 8 High Platelets
Epilogue